Hereditary Angioedema Agents
Customize your policy alerts
Sign up for Anthem Policy CC-0034 alerts
Get alerted when Policy CC-0034 changes without checking for updates manually.
Monitor payer policy activity
Clinical coverage and prior authorization criteria for medical-benefit hereditary angioedema (HAE) drugs for prophylaxis and treatment, including age limits, diagnostic verification, approval durations, and quantity limits. Affects providers prescribing or requesting authorization for HAE agents for Anthem members.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.